Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dean Kereiakes, MD
The Christ Hospital
Principal Investigator - Mathew Williams, MD
NYU Langone Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medstar Health
Washington D.C., District of Columbia, United States
- St. Vincent Heart Center of Indiana
Indianapolis, Indiana, United States
- Nyu Langone Medical Center
New York, New York, United States
- the Lindner Center for Research and Education at the Christ Hospital
Cincinnati, Ohio, United States
- Baylor Scott & White the Heart Hospital Plano
Plano, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Apr 2017
- Primary completion
- 20 Jan 2023
- Completion
- 20 Jan 2023
- Last update posted
- 31 May 2023
- Registered enrollment
- 11
- Registry id
- NCT02799823
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.